Cidara Therapeutics Stock Price on November 12, 2024
| CDTX Stock | USD 19.59 0.90 4.82% |
Below is the normalized historical share price chart for Cidara Therapeutics extending back to April 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cidara Therapeutics stands at 19.59, as last reported on the 27th of November, with the highest price reaching 20.20 and the lowest price hitting 17.82 during the day.
If you're considering investing in Cidara Stock, it is important to understand the factors that can impact its price. Cidara Therapeutics appears to be slightly risky, given 3 months investment horizon. Cidara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of standard deviation over the last 3 months. By analyzing Cidara Therapeutics' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please makes use of Cidara Therapeutics' risk adjusted performance of 0.138, and Mean Deviation of 2.81 to double-check if our risk estimates are consistent with your expectations.
At this time, Cidara Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 71.9 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.8 M). . Price To Sales Ratio is likely to drop to 1.03 in 2024. Price Earnings Ratio is likely to drop to -3.18 in 2024. Cidara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of April 2015 | 200 Day MA 13.0725 | 50 Day MA 12.4316 | Beta 0.994 |
Cidara |
Sharpe Ratio = 0.1702
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.74 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Cidara Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cidara Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.1938 | Enterprise Value Ebitda (1.64) | Price Sales 2.5625 | Shares Float 4.2 M | Wall Street Target Price 27.3333 |
Related Headline
Clearside Biomedical Headline on 12th of November 2024
Clearside Biomedical Inc Q3 2024 Earnings Revenue Surges to ... by gurufocus.com
Revenue 1.0 million for Q3 2024, surpassing the analyst estimate of 0.12 million and up from 0.9 million in Q3 2023.Net Loss 7.7 million for Q3 2024, an
Cidara Therapeutics Valuation on November 12, 2024
It is possible to determine the worth of Cidara Therapeutics on a given historical date. On November 12, 2024 Cidara was worth 13.58 at the beginning of the trading date compared to the closed value of 13.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cidara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cidara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cidara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cidara Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.51 | 13.68 | 12.89 | 13.35 | 10,773 | |
11/12/2024 | 13.58 | 13.73 | 13.14 | 13.45 | 19,359 |
| 13.31 | 14.00 | 13.27 | 13.90 | 27,119 |
| Backtest Cidara Therapeutics | | | Cidara Therapeutics History | | | Cidara Therapeutics Valuation | Previous | Next |
Cidara Therapeutics Trading Date Momentum on November 12, 2024
| On November 13 2024 Cidara Therapeutics was traded for 13.90 at the closing time. The top price for the day was 14.00 and the lowest listed price was 13.27 . The trading volume for the day was 27.1 K. The trading history from November 13, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 3.35% . The overall trading delta against the current closing price is 31.82% . |
Cidara Therapeutics Fundamentals Correlations and Trends
By evaluating Cidara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cidara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cidara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cidara Therapeutics Stock history
Cidara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cidara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cidara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cidara Therapeutics stock prices may prove useful in developing a viable investing in Cidara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.4 M | 4.6 M | |
| Net Loss | -26.8 M | -28.2 M |
Cidara Therapeutics Stock Technical Analysis
Cidara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cidara Therapeutics Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Cidara Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cidara Therapeutics November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Cidara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cidara Therapeutics shares will generate the highest return on investment. By undertsting and applying Cidara Therapeutics stock market strength indicators, traders can identify Cidara Therapeutics entry and exit signals to maximize returns
Cidara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cidara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cidara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cidara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.138 | |||
| Jensen Alpha | 0.6624 | |||
| Total Risk Alpha | 0.0424 | |||
| Sortino Ratio | 0.2062 | |||
| Treynor Ratio | 1.66 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cidara Stock Analysis
When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.